Μετάβαση στο περιεχόμενο

Ετικέταnon-small cell lung cancer

Merck’s Keytruda Nabs Another Approval, This One Under FDA’s Real-Time Program

The U.S. Food and Drug Administration (FDA) granted Merck & Co.’s Keytruda another approval, this one in combination with Alimta (pemetrexed) and platinum chemotherapy for first-line treatment of metastatic non-small cell lung cancer (NSCLC), with … Continue Reading Merck’s Keytruda Nabs Another Approval, This One Under FDA’s Real-Time Program

Takeda’s Alunbrig Shows Superiority Over Pfizer’s Xalkori in Some Lung Cancer Patients

  Takeda Pharmaceutical‘s Alunbrig (brigatinib) hit its Phase III primary endpoints of statistically significant improvement in progression-free survival compared to crizotinib (Pfizer’s Xalkori) in a subset of lung cancer patients following the first pre-specified … Continue Reading Takeda’s Alunbrig Shows Superiority Over Pfizer’s Xalkori in Some Lung Cancer Patients